In this study, we compared protein profiles in bladder cancer tissues and adjacent normal tissues by proteomics, from which we found that GPD1 protein levels were significantly downregulated in bladder cancer tissues. This evidence concerns the gene GPD1 and urinary bladder carcinoma.